Transcriptomics

Dataset Information

0

Blood-Tumor overlapping TCR repertoire predicts the clinical responses of PD-1 blockade in patients with gastrointestinal cancer

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE154539 | GEO | 2021/07/13

REPOSITORIES: GEO

Json Xml

Similar Datasets

Other Blood-Tumor overlapping TCR repertoire predicts the clinical responses of PD-1 blockade in patients with gastrointestinal cancer [TCR-Seq]
2021-07-13 | GSE154536 | GEO
Transcriptomics Blood-Tumor overlapping TCR repertoire predicts the clinical responses of PD-1 blockade in patients with gastrointestinal cancer[RNA-Seq]
2021-07-13 | GSE154538 | GEO
Unknown Greater extent of blood-tumor TCR repertoire overlap is associated with favorable clinical responses to PD-1 blockade.
| S-EPMC8353913 | biostudies-literature
Genomics Blood-Tumor overlapping TCR repertoire predicts the clinical responses of PD-1 blockade in patients with gastrointestinal cancer
| PRJNA646623 | ENA
Genomics Blood-Tumor overlapping TCR repertoire predicts the clinical responses of PD-1 blockade in patients with gastrointestinal cancer [TCR-Seq]
| PRJNA646627 | ENA
Genomics Blood-Tumor overlapping TCR repertoire predicts the clinical responses of PD-1 blockade in patients with gastrointestinal cancer[RNA-Seq]
| PRJNA646628 | ENA
Unknown Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy
| S-SCDT-EMM-2019-10293 | biostudies-other
Unknown A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma.
| S-EPMC6699626 | biostudies-literature
Unknown Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy.
| S-EPMC6609910 | biostudies-literature
Unknown Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1.
| S-EPMC7691446 | biostudies-literature